Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Economical Analysis of Different Clinical Approaches in Pre-Viability Amniorrhexis-A Case Series.

Engemise S, Thompson F, Davies W.

J Clin Med. 2014 Jan 9;3(1):25-38. doi: 10.3390/jcm3010025. Review.

2.

The effect of the levonorgestrel-releasing intrauterine system, Mirena® on mast cell numbers in women with endometriosis undergoing symptomatic treatment.

Engemise SL, Willets JM, Emembolu JO, Konje JC.

Eur J Obstet Gynecol Reprod Biol. 2011 Dec;159(2):439-42. doi: 10.1016/j.ejogrb.2011.09.007. Epub 2011 Oct 21.

PMID:
22018831
3.

Changes in glandular and stromal estrogen and progesterone receptor isoform expression in eutopic and ectopic endometrium following treatment with the levonorgestrel-releasing intrauterine system.

Engemise SL, Willets JM, Taylor AH, Emembolu JO, Konje JC.

Eur J Obstet Gynecol Reprod Biol. 2011 Jul;157(1):101-6. doi: 10.1016/j.ejogrb.2011.02.013. Epub 2011 Apr 5.

PMID:
21470761
4.

Endometriosis.

Engemise S, Gordon C, Konje JC.

BMJ. 2010 Jun 23;340:c2168. doi: 10.1136/bmj.c2168. No abstract available.

PMID:
20573761
5.

Perforated duodenal ulcer in the puerperium.

Engemise S, Oshowo A, Kyei-Mensah A.

Arch Gynecol Obstet. 2009 Mar;279(3):407-10. doi: 10.1007/s00404-008-0722-4. Epub 2008 Jul 19. No abstract available.

PMID:
18642012
6.
7.

Successful outcome following pre-viability amniorrhexis.

Engemise S, Kalu E, Haque K.

Arch Gynecol Obstet. 2007 Jul;276(1):87-9. Epub 2007 Jan 12.

PMID:
17219157

Supplemental Content

Loading ...
Support Center